Showing results (11-20 of 202) with videos related to
Sort By:
Pageof 21
Current HIV/AIDS Reports|August 11, 2005
New antiretroviral agents for the treatment of HIV infectionKristen Marks, Roy M GulickAnnual Review of Medicine|October 26, 2018
Long-Acting HIV Drugs for Treatment and PreventionRoy M Gulick, Charles FlexnerCurrent Opinion in HIV and AIDS|November 19, 2024
Future options for long-acting HIV treatment and preventionYotam Arens, Roy M GulickCurrent Opinion in HIV and AIDS|October 29, 2019
HIV treatment and prevention 2019: current standards of careNittaya Phanuphak, Roy M GulickCurrent Infectious Disease Reports|July 22, 2004
New Antiretroviral Agents for the Treatment of HIV InfectionKristen Marks, Roy M. GulickCurrent Infectious Disease Reports|April 14, 2007
New antiretroviral agentsLawrence Siegel, Roy M GulickCurrent Infectious Disease Reports|April 5, 2001
New Drugs for the Treatment of HIV InfectionKristin Lee, Roy M. GulickClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2009
Raltegravir: the first HIV type 1 integrase inhibitorCharles Hicks, Roy M GulickAIDS (London, England)|September 10, 2003
Definition of loss of virological response in trials of antiretroviral drugsSchlomo Staszewski, Caroline Sabin, Brenda Dauer, et al.Annual Review of Medicine|November 1, 2011
CCR5 antagonism in HIV infection: current concepts and future opportunitiesTimothy J Wilkin, Roy M GulickPageof 21